WHO's observation on plasma therapy
The World Health Organization (WHO) said there is very little evidence of the effectiveness of plasma therapy in coronary therapy and that its effectiveness is still under consideration.
On Monday (August 25), WHO chief scientist Soumya Swaminathan stressed that the effectiveness of plasma treatment has not yet been proven. So far we have found very little evidence where it was safe and effective.
He said there are several clinical trials going on around the world to see plasma treatments. However, only a few of these results have been reported. The results are not final yet. The trials were relatively small. In some cases, the results have been good, but not final. We're still tracking to see where reviews are being moved or shown. In fact, there is very little evidence at the moment.
Senior Adviser to the Director General of the WHO. Bruce Elward warns that subsequent side effects of plasma can range from mild cold and rectum to more serious lung problems and blood circulation overload.
Earlier on Sunday, the US Food and Drug Administration (FDA) approved the use of plasma in the treatment of Covid-19 patients on an emergency basis. According to the FDA, their initial tests showed the treatment was safe. However, further testing is needed to prove its effectiveness.
Plasma treatment Plasma or plasma is used in people who have recovered and developed immunity after being infected with the coronavirus.
Scientists hope that if plasma is taken from the body of a healthy person and given to a sick person, antibodies will be produced in his body. However, researchers have not yet found any definite evidence of the success of this treatment. However, this method is being used in the treatment of Covid-19 in many countries of the world.